Small Cell Lung Cancer
Small Cell Lung Cancer
Advertisement
Cecilia BrownSmall Cell Lung Cancer | May 20, 2024
The treatment is the first and only bispecific T-cell engager therapy for advanced SCLC.
Read More
Cecilia BrownSmall Cell Lung Cancer | May 17, 2024
Global clinical trials are scheduled to begin after IND approval is received for phase 2 trials in the US and Europe.
Cecilia BrownLung Cancer | May 15, 2024
The primary end point of the RESILIENT trial was OS.
Kaitlyn KoskoSmall Cell Lung Cancer | April 19, 2024
The timing of chemotherapy given to patients with SCLC does not have a statistically significant impact on OS.
Kaitlyn KoskoSmall Cell Lung Cancer | April 18, 2024
The timing of chemotherapy given to patients with SCLC does not have a statistically significant effect on OS.
Mary GreccoSmall Cell Lung Cancer | March 26, 2024
Chemotherapy-induced myelosuppression among patients with extensive-stage SCLC is poorly understood.
Mary GreccoSmall Cell Lung Cancer | March 26, 2024
The DeLLphi-301 study that evaluated patients with advanced SCLC.
Mary GreccoSmall Cell Carcinoma | March 22, 2024
Lurbinectedin monotherapy is currently being studied in Jazz EMERGE 402 study in patients with metastatic SCLC.
Kaitlyn KoskoSmall Cell Lung Cancer | February 27, 2024
Researchers from the US and Italy have identified a biomarker that can distinguish between SCLC and SCC.
Kaitlyn KoskoSmall Cell Lung Cancer | January 25, 2024
Berzosertib plus topotecan significantly improves OS but not PFS in patients with relapsed small cell lung cancer.
Eileen Koutnik-FotopoulosSmall Cell Lung Cancer | December 27, 2023
A study analyzed the efficacy and safety of radiotherapy in patients with SCLC with brain metastases.
Kaitlyn KoskoSmall Cell Lung Cancer | December 26, 2023
Co-targeting neuroendocrine and non-NE cells may help reduce small cell lung cancer progression.
Mary GreccoWCLC 2023 | December 20, 2023
A study sought to ascertain the role of occupation in the risk of SCLC and adenocarcinoma in Spanish women.
Mary GreccoWCLC 2023 | December 19, 2023
The results of a study that aimed to subclassify SCLC based on certain immunoexpressions.
The Fellow on CallThe Fellow on Call | September 22, 2023
The group makes the distinction between non-small cell lung cancer, used as an umbrella term, and small cell lung cancer.
Oncology BrothersOncology Brothers | September 26, 2023
In this podcast episode, The Oncology Brothers are joined by Dr. Estelamari Rodriguez, University of Miami Health ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Researchers investigated the effects of adding programmed cell death 1 (PD-1) inhibition to chemotherapy in patients ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Researchers set out to characterize survival outcomes in patients with small cell lung cancer (SCLC) treated with ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
Immune checkpoint inhibitors (ICIs) are approved for treatment of small cell lung cancer (SCLC). However, according to ...
Patrick DalySmall Cell Lung Cancer | September 21, 2023
In part one of the phase II/III RESILIENT trial, led by Luis Paz-Ares, researchers evaluated outcomes of second-line ...
Advertisement
Advertisement
Advertisement
Latest News

May 24, 2024